Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic Subjects

Status:
Completed

Trial end date:
2007-10-01

Target enrollment:

Participant gender:

A dose-ranging study evaluating safety, metabolism and therapeutic dosing of three multiple dose levels of GLY-230 in healthy and diabetic subjects

Phase 1/Phase 2

Glycadia